Literature DB >> 25489083

Restoration of visual function by expression of a light-gated mammalian ion channel in retinal ganglion cells or ON-bipolar cells.

Benjamin M Gaub1, Michael H Berry2, Amy E Holt2, Andreas Reiner2, Michael A Kienzler2, Natalia Dolgova3, Sergei Nikonov4, Gustavo D Aguirre3, William A Beltran3, John G Flannery5, Ehud Y Isacoff6.   

Abstract

Most inherited forms of blindness are caused by mutations that lead to photoreceptor cell death but spare second- and third-order retinal neurons. Expression of the light-gated excitatory mammalian ion channel light-gated ionotropic glutamate receptor (LiGluR) in retinal ganglion cells (RGCs) of the retina degeneration (rd1) mouse model of blindness was previously shown to restore some visual functions when stimulated by UV light. Here, we report restored retinal function in visible light in rodent and canine models of blindness through the use of a second-generation photoswitch for LiGluR, maleimide-azobenzene-glutamate 0 with peak efficiency at 460 nm (MAG0(460)). In the blind rd1 mouse, multielectrode array recordings of retinal explants revealed robust and uniform light-evoked firing when LiGluR-MAG0(460) was targeted to RGCs and robust but diverse activity patterns in RGCs when LiGluR-MAG0(460) was targeted to ON-bipolar cells (ON-BCs). LiGluR-MAG0(460) in either RGCs or ON-BCs of the rd1 mouse reinstated innate light-avoidance behavior and enabled mice to distinguish between different temporal patterns of light in an associative learning task. In the rod-cone dystrophy dog model of blindness, LiGluR-MAG0(460) in RGCs restored robust light responses to retinal explants and intravitreal delivery of LiGluR and MAG0(460) was well tolerated in vivo. The results in both large and small animal models of photoreceptor degeneration provide a path to clinical translation.

Entities:  

Keywords:  azobenzene photoswitches; optogenetic pharmacology; retinal gene therapy; retinitis pigmentosa; visual prosthetics

Mesh:

Substances:

Year:  2014        PMID: 25489083      PMCID: PMC4280620          DOI: 10.1073/pnas.1414162111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  Retinal organization in the retinal degeneration 10 (rd10) mutant mouse: a morphological and ERG study.

Authors:  Claudia Gargini; Eva Terzibasi; Francesca Mazzoni; Enrica Strettoi
Journal:  J Comp Neurol       Date:  2007-01-10       Impact factor: 3.215

2.  Mechanisms of photoswitch conjugation and light activation of an ionotropic glutamate receptor.

Authors:  Pau Gorostiza; Matthew Volgraf; Rika Numano; Stephanie Szobota; Dirk Trauner; Ehud Y Isacoff
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

3.  Parallel processing in retinal ganglion cells: how integration of space-time patterns of excitation and inhibition form the spiking output.

Authors:  Botond Roska; Alyosha Molnar; Frank S Werblin
Journal:  J Neurophysiol       Date:  2006-03-01       Impact factor: 2.714

4.  Neural reprogramming in retinal degeneration.

Authors:  Robert E Marc; Bryan W Jones; James R Anderson; Krista Kinard; David W Marshak; John H Wilson; Theodore Wensel; Robert J Lucas
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-07       Impact factor: 4.799

5.  Photoswitching of cell surface receptors using tethered ligands.

Authors:  Andreas Reiner; Ehud Y Isacoff
Journal:  Methods Mol Biol       Date:  2014

6.  Production and characterization of adeno-associated viral vectors.

Authors:  Joshua C Grieger; Vivian W Choi; R Jude Samulski
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

7.  Differential responses to high-frequency electrical stimulation in ON and OFF retinal ganglion cells.

Authors:  Perry Twyford; Changsi Cai; Shelley Fried
Journal:  J Neural Eng       Date:  2014-02-21       Impact factor: 5.379

Review 8.  Photoreceptor cell death mechanisms in inherited retinal degeneration.

Authors:  Javier Sancho-Pelluz; Blanca Arango-Gonzalez; Stefan Kustermann; Francisco Javier Romero; Theo van Veen; Eberhart Zrenner; Per Ekström; François Paquet-Durand
Journal:  Mol Neurobiol       Date:  2008-11-04       Impact factor: 5.590

9.  Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration.

Authors:  Pamela S Lagali; David Balya; Gautam B Awatramani; Thomas A Münch; Douglas S Kim; Volker Busskamp; Constance L Cepko; Botond Roska
Journal:  Nat Neurosci       Date:  2008-04-27       Impact factor: 24.884

10.  Restoration of visual function in retinal degeneration mice by ectopic expression of melanopsin.

Authors:  Bin Lin; Amane Koizumi; Nobushige Tanaka; Satchidananda Panda; Richard H Masland
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-03       Impact factor: 11.205

View more
  57 in total

Review 1.  Pulse trains to percepts: the challenge of creating a perceptually intelligible world with sight recovery technologies.

Authors:  Ione Fine; Geoffrey M Boynton
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-19       Impact factor: 6.237

2.  Transplantation of human embryonic stem cell-derived retinal tissue in two primate models of retinal degeneration.

Authors:  Hiroshi Shirai; Michiko Mandai; Keizo Matsushita; Atsushi Kuwahara; Shigenobu Yonemura; Tokushige Nakano; Juthaporn Assawachananont; Toru Kimura; Koichi Saito; Hiroko Terasaki; Mototsugu Eiraku; Yoshiki Sasai; Masayo Takahashi
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-22       Impact factor: 11.205

3.  Highly Efficient Delivery of Adeno-Associated Viral Vectors to the Primate Retina.

Authors:  Shannon E Boye; John J Alexander; C Douglas Witherspoon; Sanford L Boye; James J Peterson; Mark E Clark; Kristen J Sandefer; Chris A Girkin; William W Hauswirth; Paul D Gamlin
Journal:  Hum Gene Ther       Date:  2016-08       Impact factor: 5.695

4.  Intravitreal delivery of a novel AAV vector targets ON bipolar cells and restores visual function in a mouse model of complete congenital stationary night blindness.

Authors:  Miranda L Scalabrino; Sanford L Boye; Kathryn M H Fransen; Jennifer M Noel; Frank M Dyka; Seok Hong Min; Qing Ruan; Charles N De Leeuw; Elizabeth M Simpson; Ronald G Gregg; Maureen A McCall; Neal S Peachey; Shannon E Boye
Journal:  Hum Mol Genet       Date:  2015-08-26       Impact factor: 6.150

Review 5.  Synapses in the spotlight with synthetic optogenetics.

Authors:  Shai Berlin; Ehud Y Isacoff
Journal:  EMBO Rep       Date:  2017-04-10       Impact factor: 8.807

6.  A New Promoter Allows Optogenetic Vision Restoration with Enhanced Sensitivity in Macaque Retina.

Authors:  Antoine Chaffiol; Romain Caplette; Céline Jaillard; Elena Brazhnikova; Mélissa Desrosiers; Elisabeth Dubus; Laëtitia Duhamel; Emilie Macé; Olivier Marre; Patrick Benoit; Philippe Hantraye; Alexis-Pierre Bemelmans; Ernst Bamberg; Jens Duebel; José-Alain Sahel; Serge Picaud; Deniz Dalkara
Journal:  Mol Ther       Date:  2017-07-20       Impact factor: 11.454

Review 7.  Light-Switchable Ion Channels and Receptors for Optogenetic Interrogation of Neuronal Signaling.

Authors:  Wan-Chen Lin; Richard H Kramer
Journal:  Bioconjug Chem       Date:  2018-02-21       Impact factor: 4.774

Review 8.  Light-induced regulation of ligand-gated channel activity.

Authors:  Piotr Bregestovski; Galyna Maleeva; Pau Gorostiza
Journal:  Br J Pharmacol       Date:  2017-10-06       Impact factor: 8.739

Review 9.  Evaluation of Dose and Safety of AAV7m8 and AAV8BP2 in the Non-Human Primate Retina.

Authors:  Pavitra S Ramachandran; Vivian Lee; Zhangyong Wei; Ji Yun Song; Giulia Casal; Therese Cronin; Keirnan Willett; Rachel Huckfeldt; Jessica I W Morgan; Tomas S Aleman; Albert M Maguire; Jean Bennett
Journal:  Hum Gene Ther       Date:  2016-10-17       Impact factor: 5.695

10.  Optical Control of Dopamine Receptors Using a Photoswitchable Tethered Inverse Agonist.

Authors:  Prashant C Donthamsetti; Nils Winter; Matthias Schönberger; Joshua Levitz; Cherise Stanley; Jonathan A Javitch; Ehud Y Isacoff; Dirk Trauner
Journal:  J Am Chem Soc       Date:  2017-12-13       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.